Premium
An Altered Response by Psoriatic Keratinocytes to Gamma Interferon
Author(s) -
BAKER B. S.,
POWLES A. V.,
VALDIMARSSON H.,
FRY L.
Publication year - 1988
Publication title -
scandinavian journal of immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.934
H-Index - 88
eISSN - 1365-3083
pISSN - 0300-9475
DOI - 10.1111/j.1365-3083.1988.tb01507.x
Subject(s) - psoriasis , keratinocyte , interferon gamma , epidermis (zoology) , interferon , thymidine , medicine , cell culture , in vivo , immunology , in vitro , pathology , biology , cytokine , genetics , microbiology and biotechnology , anatomy , biochemistry
To determine whether psoriatic keratinocytes differ from normal keratinocytes in their response to gamma interferon, epidermal cell suspensions from normal and from lesional and uninvolved psoriatic skin were cultured in the presence of gamma interferon and the induction of HLA‐DR expression and inhibition of cell growth were measured The addition of 10 2 units of gamma interferon/ml during 7‐day culture period significantly increased mean HLA‐DR + cell numbers in 21 epidermal suspensions of normal from 3.9 to 24.1% (P<0.0001), uninvolved psoriatic from 8.4 to 33.1% ( P <0.01), and to a lesser extent lesional psoriatic biopsies from 12.6 to 18.3% ( P <0.01). However, the increase in HLA‐DR + cell numbers in these latter cultures was significantly less than that observed in either normal or uninvolved psoriatic epidermal cell cultures ( P <0.0001). Furthermore, [ 3 H]thymidine incorporation was substantially decreased by gamma interferon in 16 out of 22 (73%) cultures of normal epidermal cells; this decrease was statistically significant ( P <0.0l). In contrast, only 4 out of 11 (36%) lesional and 9 out of 21 (43%) uninvolved psoriatic epidermal cultures showed comparable inhibition of proliferation. These findings suggest that psoriatic keratinocytes have an altered response to gamma interferon: this could explain the infrequency of keratinocyte HLA‐DR expression in psoriatic plaques in vivo and may also contribute to the increased epidermal proliferation that characterizes this disease.